Stem Cell Transplant Complications Clinical Trials
2 recruiting trials for Stem Cell Transplant Complications. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Stem Cell Transplant Complications clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 2 / Phase 3 is the largest group at 50% (1 studies); the largest phase groups are Phase 2 / Phase 3: 1, Phase 2: 1.
Research is led by Peking University People's Hospital (1), University of Calgary (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Decitabine (drug, 1 trial), followed by mBU/CY and ATG, mBU/CY.
Track Stem Cell Transplant Complications trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) remains one of the currently available curative therapies for acute leukemia (AL). Leukemia relapse is one of the...
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling...
The aim of this study to evaluate the safety and efficacy of a nonmyeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Stem Cell Transplant Complications, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Stem Cell Transplant Complications, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Stem Cell Transplant Complications, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.